Currently, Lexicon Pharmaceuticals Inc’s (LXRX) stock is trading at $0.81, marking a gain of 3.34% from last night’s close. At this price, the stock is -78.25% below its 52-week high of $3.73 and 30.74% above its 52-week low of $0.62. Based on the past 30-day period, the stock price is -24.68% below the high and +24.39% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, LXRX’s SMA-200 is $1.4427.
As well, it is important to consider LXRX stock ratios such as price-to-sales, which is currently 56.06.LXRX’s price to book ratio for the most recent quarter was 1.64, resulting in an 1.13 price to cash per share for the period.
How does Lexicon Pharmaceuticals Inc (LXRX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 6 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.33 in simple terms.
Lexicon Pharmaceuticals Inc (LXRX): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 4 different analysts, who are expecting earnings to fall in between the range of -0.08 and -0.16 with an average Earnings Estimate of -0.11 which is in contrast with the last year earnings estimate of -0.20 and also replicates 45.00% growth rate year over year.
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) Ownership Details
I will give a breakdown of the key shareholders in Lexicon Pharmaceuticals Inc (LXRX). Recent figures show that the company’s insiders hold 1.15% of shares. A total of 169 institutional investors hold shares in the company, making 84.47% of its stock and 85.46% of its float.
Dec 31, 2024, it was reported that the Company’s largest institutional holder is Artal Group S.A. holding total of 136.18 shares that make 37.67% of the company’s total number of shares and are currently priced at 111.65 million.
The securities firm FMR, LLC holds 51.97 shares of LXRX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 14.38%, and the holding percentage of shares is valued at 42.61 million.
An overview of Lexicon Pharmaceuticals Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Lexicon Pharmaceuticals Inc (LXRX) traded 4,624,232 shares per day, with a moving average of $0.7984 and price change of +0.1310. With the moving average of $0.7757 and a price change of +0.1081, about 5,082,361 shares changed hands on average over the past 50 days. Finally, LXRX’s 100-day average volume is 4,337,498 shares, alongside a moving average of $1.0984 and a price change of -0.8390.
